Other Events ·
BeOne Medicines Ltd. concluded a statutory tax audit in China, resulting in a settlement agreement with local tax…
ONCBeOne Medicines Ltd.
BeOne Medicines Ltd. concluded a statutory tax audit in China, resulting in a settlement agreement with local tax authorities to make an income tax payment of approximately RMB 446 million. This payment, which includes surcharges and related interest, is expected to be recognized in the second quarter of fiscal 2026 financial statements. BeOne Medicines Ltd. is a pharmaceutical company focused on developing medicines for various therapeutic areas.